XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net income $ 58 $ 35 $ 160
Add (deduct) adjustments to reconcile net income to net cash flows from operating activities      
Depreciation, amortization and accretion 656 700 678
Bad debts expense 104 132 56
Stock-based compensation expense 23 24 27
Deferred income taxes, net 47 33 41
Equity in earnings of unconsolidated entities (158) (158) (179)
Distributions from unconsolidated entities 150 145 176
Loss on impairment of licenses 0 3 0
(Gain) loss on asset disposals, net 17 19 23
(Gain) loss on sale of business and other exit costs, net 0 (1) (2)
(Gain) loss on license sales and exchanges, net (2) 0 0
Other operating activities 6 9 33
Changes in assets and liabilities from operations      
Accounts receivable 17 (59) (27)
Equipment installment plans receivable (20) (199) (116)
Inventory 62 (88) (27)
Accounts payable (85) 12 (57)
Customer deposits and deferred revenues (9) 47 40
Accrued taxes 0 121 (41)
Other assets and liabilities 0 57 17
Net cash provided by operating activities 866 832 802
Cash flows from investing activities      
Cash paid for additions to property, plant and equipment (608) (602) (724)
Cash paid for licenses (130) (585) (1,302)
Advance payments for license acquisitions 0 0 (20)
Other investing activities 17 8 10
Net cash used in investing activities (721) (1,179) (2,036)
Cash flows from financing activities      
Issuance of long-term debt 315 800 1,342
Repayment of long-term debt (453) (329) (1,118)
Issuance of short-term debt 0 110 0
Repayment of short-term debt (60) (50) 0
Common Shares reissued for benefit plans, net of tax payments (6) (5) (16)
Repurchase of Common Shares 0 (43) (31)
Payment of debt issuance costs (1) (1) (22)
Distributions to noncontrolling interests (3) (3) (3)
Cash paid for software license agreements (66) (22) (9)
Other financing activities 0 (1) (1)
Net cash provided by (used in) financing activities (274) 456 142
Net increase (decrease) in cash, cash equivalents and restricted cash (129) 109 (1,092)
Cash, cash equivalents and restricted cash      
Beginning of period 308 199 1,291
End of period $ 179 $ 308 $ 199